Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
Anyone with asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
19 September 2017
Manchester's Girlguides are being urged to help the elderly with a new badge incentivising youngsters to tackle senior loneliness.
[more...]
16 September 2017
Holidaymakers are being evacuated as winds up to 200km per hour hit Central Vietnam, with Typhoon Doksuri damaging houses, roads and infrastructure.
15 September 2017
People in parts of East Anglia are eight times more likely to survive liver disease than Blackpool residents, according to new data by Public Health England (PHE).
14 September 2017
A non-invasive alternative to gastric bypass surgery that helps people with Type 2 diabetes lose weight is being recommended for widespread use by NHS experts.
13 September 2017
Almost half of UK adults travelling to areas at risk of malaria are not covering themselves by taking medication, despite recommendations made by the NHS and world health organisations.
12 September 2017
A new health warning has been issued by scientists in Sweden, suggesting e-cigarettes with nicotine could lead to an increased risk of heart attacks and strokes.
09 September 2017
Researchers have developed a futuristic pen-like device that can tell whether someone has cancer much faster than current technology.
08 September 2017
A staffing crisis in the NHS is seeing cancer patients turned away from their GP surgery and instead visiting A&E, a report has claimed.
07 September 2017
Whether it's binge-watching box-sets, shopping for clothes, chatting to friends or picking up work emails, staying connected is pretty much essential to everyday life.
06 September 2017
Around 1 in 2 GPs do not know that black men have a higher risk of developing prostate cancer, research has suggested.
05 September 2017
Many middle-aged men have hearts in a condition that makes the organ seem older than the men's actual age, a new study has revealed.
02 September 2017
Every cancer diagnosis should involve a discussion about stress, according to an expert investigating the biological impact of "fight-or-flight" responses.